Conversation

Replying to
$Siox market cap 40m have 82m cash, GM1/GM2 FDA vouchers worth over 400m for rare orphan diseases, both first in class therapies with fast track designation, meeting with FDA in May, GM1 data astounding, Low float.
1
Show replies